What is Fathom?
Founded in 2016 and headquartered in San Francisco, Fathom operates as a specialized medical coding automation platform. The company addresses the persistent challenges of administrative overhead in healthcare by deploying sophisticated machine learning models to automate the coding process. This technology is designed to reduce human error, decrease turnaround times, and optimize revenue cycle management for large-scale medical institutions. By integrating directly into existing electronic health record systems, Fathom provides a seamless transition toward autonomous medical coding, effectively bridging the gap between clinical documentation and financial reimbursement.
How much funding has Fathom raised?
Fathom has raised a total of $46.1M across 2 funding rounds:
Debt
$150K
Series B
$46M
Debt (2020): $150K with participation from PPP
Series B (2022): $46M led by Alkeon Capital, Lightspeed Venture Partners, Cedars-Sinai, and Vituity’s Inflect Health
Key Investors in Fathom
Alkeon Capital
Alkeon Capital Management is a venture capital firm with over two decades of experience investing in transformative companies throughout their lifecycle, focusing on growth and innovation across multiple industries.
Lightspeed Venture Partners
Lightspeed Venture Partners is a global multistage venture capital firm that invests in early and growth-stage technology companies across sectors such as enterprise software, fintech, and infrastructure.
Cedars-Sinai
Cedars-Sinai is a non-profit academic medical center that provides clinical programs ranging from primary care to specialized treatments for rare and complex illnesses.
What's next for Fathom?
Looking ahead, Fathom is poised to leverage its recent capital injection to scale its engineering and sales organizations. The company's focus remains on enhancing the accuracy and breadth of its automation capabilities, particularly as it navigates the complexities of diverse medical specialties. With the backing of institutional investors and strategic healthcare partners, Fathom is well-positioned to capture a larger share of the medical coding market. Future growth will likely center on deepening integrations with major hospital networks and refining its proprietary algorithms to handle increasingly complex clinical scenarios, thereby driving long-term value for its enterprise clients.
See full Fathom company page
